Derbyshire people are urged to take part in Big Butterfly Count to protect endangered species
Wildlife lovers have just a few days left to take part in a project to record butterfly sightings in their garden.
Source: derbyshiretimes.co.uk
Page 5 - Eric Easom News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Eric Easom. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Eric Easom Today - Breaking & Trending Today
AN2 Therapeutics Initiates Pivotal Phase 2/3 Trial
AN2 is developing epetraborole as a once-daily, orally administered treatment with a novel mechanism of action for patients with NTM lung disease, with an...
Source: globenewswire.com
AN2 Therapeutics Appoints Dr. Mel Spigelman, M.D. to its Board of Directors
/PRNewswire/ -- AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases...
Source: prnewswire.com
AN2 Therapeutics Appoints Dr. Mel Spigelman, M.D. to its Board of Directors
/PRNewswire/ -- AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases...
Source: prnewswire.com
With lung drug from Pfizer in hand, AN2 tests IPO waters in turbulent market
Two biotechs are braving the roiling financial markets to raise money for clinical trials. AN2 Therapeutics is preparing for a pivotal test of its boron-based drug candidate for a rare, chronic lung disease. Okyo Pharma also filed IPO paperwork as it looks to advance to the clinic with its dry eye disease drug.
Source: medcitynews.com